Your browser doesn't support javascript.
loading
A framework to guide dose & regimen strategy for clinical drug development.
Sander, Oliver; Magnusson, Baldur; Ludwig, Inga; Jullion, Astrid; Meille, Christophe; Lorand, Daniel; Bornkamp, Björn; Hinder, Markus; Kovacs, Steven J; Looby, Michael.
Affiliation
  • Sander O; Novartis Pharma AG, Basel, Switzerland.
  • Magnusson B; Novartis Pharma AG, Basel, Switzerland.
  • Ludwig I; Novartis Pharma AG, Basel, Switzerland.
  • Jullion A; Novartis Pharma AG, Basel, Switzerland.
  • Meille C; Novartis Pharma AG, Basel, Switzerland.
  • Lorand D; Novartis Pharma AG, Basel, Switzerland.
  • Bornkamp B; Novartis Pharma AG, Basel, Switzerland.
  • Hinder M; Translational Medicine, Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Kovacs SJ; Translational Medicine, Novartis Institutes for BioMedical Research, East Hanover, New Jersey, USA.
  • Looby M; Novartis Pharma AG, Basel, Switzerland.
CPT Pharmacometrics Syst Pharmacol ; 10(11): 1276-1280, 2021 11.
Article de En | MEDLINE | ID: mdl-34562310
ABSTRACT
Optimizing new drug therapies remains a challenge for clinical development, despite the use of ever more sophisticated quantitative methodologies. Although conceptually simple, the idea of finding the right treatment at the right dose for the right patient to ensure an appropriate balance of risks and benefits is challenging and requires a multidisciplinary approach. In this paper, we present a framework developed as a tool for organizing knowledge and facilitating collaboration in development teams.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Développement de médicament Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: CPT Pharmacometrics Syst Pharmacol Année: 2021 Type de document: Article Pays d'affiliation: Suisse

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Développement de médicament Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: CPT Pharmacometrics Syst Pharmacol Année: 2021 Type de document: Article Pays d'affiliation: Suisse